North South Ventures is a cross-border venture capital fund that focuses on early-stage medical companies. The firm is strategically co-located in academic medical superclusters such as Stanford/UCSF and the University of Toronto, giving it access to proprietary deal flow from top US and Canadian academic centers. North South Ventures typically invests in seed and Series A rounds, supporting companies in the biotech, medical device, and digital health/AI sectors.
The firm's notable portfolio companies include Droplet Biosciences, Persephone Biosciences, and YourChoice Therapeutics. North South Ventures has a robust track record with over 350 medical portfolio companies and more than 40 FDA approvals, contributing to $10 billion in cumulative funding and multiple billion-dollar IPOs. The firm emphasizes a "people first, companies second" investment philosophy and offers unique value-add services through its deep connections in academic and medical research communities.
North South Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix
North South Ventures: A cross-border VC fund, investing in early-stage med companies, with $4B+ funding and 40+ FDA approvals.
Concentration shown as share of disclosed investments by stage.
Northpond Ventures
Northwest Technology Ventures
nwtechventures.com
North Coast Ventures
northcoast.vc
Northzone
northzone.com
NeuroVentures Capital
neuroventures.com
Nest.Bio Venture
nest.bio
NorthSpring Capital Partners
Norte Ventures
norte.ventures
MedScience Ventures
Northern Light Venture Capital
nlvc.com
Northstar.vc
northstar.vc
North America Venture Fund
North Coast Technology Investors
True North Venture Partners
truenorthvp.com
VentureSouth
venturesouth.vc
